| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rosuvastatin Calcium | FAERS: 7 | US FAERS | |
| 2 | rofecoxib | FAERS: 6 | US FAERS | |
| 3 | Sildenafil Citrate | FAERS: 4 | US FAERS | |
| 4 | Venlafaxine Hydrochloride | FAERS: 4 | US FAERS | |
| 5 | Valsartan | FAERS: 3 | US FAERS | |
| 6 | Zoledronic Acid | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | ambrisentan | FAERS: 3 | US FAERS | |
| 8 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 2 | US FAERS | |
| 9 | Lenalidomide | FAERS: 2 | US FAERS | |
| 10 | Tiotropium Bromide | FAERS: 2 | US FAERS | |
| 11 | macitentan | FAERS: 2 | US FAERS | |
| 12 | patiromer | FAERS: 2 | US FAERS | |
| 13 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 14 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 15 | Abiraterone Acetate | FAERS: 1 | US FAERS | |
| 16 | Acetaminophen | FAERS: 1 | US FAERS | |
| 17 | Amiodarone | FAERS: 1 | US FAERS | |
| 18 | Amlodipine | FAERS: 1 | US FAERS | |
| 19 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 20 | Atorvastatin | FAERS: 1 | US FAERS | |
| 21 | Bosentan | FAERS: 1 | US FAERS | |
| 22 | Celecoxib | FAERS: 1 | US FAERS | |
| 23 | Cinacalcet | FAERS: 1 | US FAERS | |
| 24 | Citalopram | FAERS: 1 | US FAERS | |
| 25 | Cyclosporine | FAERS: 1 | US FAERS | |
| 26 | Daptomycin | FAERS: 1 | US FAERS | |
| 27 | Dasatinib | FAERS: 1 | US FAERS | |
| 28 | Diovan Hct | FAERS: 1 | US FAERS | |
| 29 | Diphenhydramine | FAERS: 1 | US FAERS | |
| 30 | Docetaxel | FAERS: 1 | US FAERS | |
| 31 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 32 | Fentanyl | FAERS: 1 | US FAERS | |
| 33 | Furosemide | FAERS: 1 | US FAERS | |
| 34 | Hydralazine | FAERS: 1 | US FAERS | |
| 35 | Insulin Glargine | FAERS: 1 | US FAERS | |
| 36 | LCZ 696 | FAERS: 1 | US FAERS | |
| 37 | Letrozole | FAERS: 1 | US FAERS | |
| 38 | Levetiracetam | FAERS: 1 | US FAERS | |
| 39 | MDV 3100 | FAERS: 1 | US FAERS | |
| 40 | Methotrexate | FAERS: 1 | US FAERS | |
| 41 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 42 | Olanzapine pamoate | FAERS: 1 | US FAERS | |
| 43 | Omeprazole | FAERS: 1 | US FAERS | |
| 44 | Oseltamivir | FAERS: 1 | US FAERS | |
| 45 | Ranolazine | FAERS: 1 | US FAERS | |
| 46 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 47 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 48 | Solifenacin Succinate | FAERS: 1 | US FAERS | |
| 49 | Teriparatide | FAERS: 1 | US FAERS | |
| 50 | Thalidomide | FAERS: 1 | US FAERS | |
| 51 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 52 | Viekira Pak | FAERS: 1 | US FAERS | |
| 53 | Warfarin | FAERS: 1 | US FAERS | |
| 54 | apremilast | FAERS: 1 | US FAERS | |
| 55 | eltrombopag | FAERS: 1 | US FAERS | |
| 56 | eluxadoline | FAERS: 1 | US FAERS | |
| 57 | idelalisib | FAERS: 1 | US FAERS | |
| 58 | ixazomib | FAERS: 1 | US FAERS | |
| 59 | paricalcitol | FAERS: 1 | US FAERS | |
| 60 | pirfenidone | FAERS: 1 | US FAERS | |
| 61 | pomalidomide | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 62 | tofacitinib | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 63 | valdecoxib | FAERS: 1 | US FAERS | |
| 64 | venetoclax | FAERS: 1 | US FAERS | |
| 65 | Cetirizine | OFFSIDES | ||
| 66 | Cinacalcet | OFFSIDES | ||
| 67 | Estradiol | OFFSIDES | ||
| 68 | Formoterol Fumarate | OFFSIDES | ||
| 69 | Lanthanum carbonate hydrate | OFFSIDES | ||
| 70 | Leflunomide | OFFSIDES | ||
| 71 | Mometasone Furoate | OFFSIDES | ||
| 72 | Nisoldipine | OFFSIDES | ||
| 73 | PCI 32765 | Canada Vigilance: 1 | Canada Vigilance | |
| 74 | Ribavirin | OFFSIDES | ||
| 75 | Salmeterol Xinafoate | OFFSIDES | ||
| 76 | Sertraline | OFFSIDES | ||
| 77 | efavirenz | OFFSIDES | ||
| 78 | fludarabine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.